1. Home
  2. EDSA vs MLGO Comparison

EDSA vs MLGO Comparison

Compare EDSA & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • MLGO
  • Stock Information
  • Founded
  • EDSA 2015
  • MLGO 2018
  • Country
  • EDSA Canada
  • MLGO China
  • Employees
  • EDSA 16
  • MLGO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • MLGO EDP Services
  • Sector
  • EDSA Health Care
  • MLGO Technology
  • Exchange
  • EDSA Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • EDSA 14.7M
  • MLGO 15.6M
  • IPO Year
  • EDSA N/A
  • MLGO N/A
  • Fundamental
  • Price
  • EDSA $2.39
  • MLGO $14.66
  • Analyst Decision
  • EDSA Strong Buy
  • MLGO
  • Analyst Count
  • EDSA 2
  • MLGO 0
  • Target Price
  • EDSA $13.00
  • MLGO N/A
  • AVG Volume (30 Days)
  • EDSA 30.7K
  • MLGO 33.0M
  • Earning Date
  • EDSA 08-08-2025
  • MLGO 04-28-2025
  • Dividend Yield
  • EDSA N/A
  • MLGO N/A
  • EPS Growth
  • EDSA N/A
  • MLGO N/A
  • EPS
  • EDSA N/A
  • MLGO 16.40
  • Revenue
  • EDSA N/A
  • MLGO $74,185,505.00
  • Revenue This Year
  • EDSA N/A
  • MLGO N/A
  • Revenue Next Year
  • EDSA N/A
  • MLGO N/A
  • P/E Ratio
  • EDSA N/A
  • MLGO $1.08
  • Revenue Growth
  • EDSA N/A
  • MLGO N/A
  • 52 Week Low
  • EDSA $1.55
  • MLGO $0.50
  • 52 Week High
  • EDSA $5.59
  • MLGO $59.40
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 73.15
  • MLGO 32.95
  • Support Level
  • EDSA $1.89
  • MLGO $18.00
  • Resistance Level
  • EDSA $2.23
  • MLGO $26.40
  • Average True Range (ATR)
  • EDSA 0.11
  • MLGO 3.16
  • MACD
  • EDSA 0.04
  • MLGO 2.76
  • Stochastic Oscillator
  • EDSA 81.54
  • MLGO 7.56

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: